Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
Am J Hematol
    August 2022
  1. NAGALAPURAM V, Kanter J
    Multi-organ dysfunction secondary to abrupt discontinuation of voxelotor in a patient with severe sickle cell disease.
    Am J Hematol. 2022;97:E318-E320.
    >> Share

  2. GRAF M, Tuly R, Gallagher M, Sullivan J, et al
    Value of a cure for sickle cell disease in reducing economic disparities.
    Am J Hematol. 2022;97:E289-E291.
    >> Share

  3. LE MONNIER O, Joseph L, Bodard S, Boudhabhay I, et al
    Hepato-splenic abscesses in a sickle cell disease patient.
    Am J Hematol. 2022;97:1118-1119.
    >> Share

  4. LAI YR, Cappellini MD, Aydinok Y, Porter J, et al
    An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results.
    Am J Hematol. 2022;97:E281-E284.
    >> Share

  5. MANSOUR-HENDILI L, Flamarion E, Michel M, Morbieu C, et al
    Acquired spherocytosis due to somatic ANK1 mutations as a manifestation of clonal hematopoiesis in elderly patients.
    Am J Hematol. 2022;97:E285-E288.
    >> Share

  6. OSUNKWO I, James J, El-Rassi F, Nero A, et al
    Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey.
    Am J Hematol. 2022;97:1055-1064.
    >> Share

    July 2022
  7. POUCHELON C, Lafont C, Lafarge A, Comont T, et al
    Characteristics and Outcome of Adults With Severe Autoimmune Hemolytic Anemia Admitted to the Intensive Care Unit: Results From A Large French Observational Study.
    Am J Hematol. 2022 Jul 24. doi: 10.1002/ajh.26665.
    >> Share

  8. KARKOSKA K, Pfeiffer A, Beebe DW, Quinn CT, et al
    Early hydroxyurea use is neuroprotective in children with sickle cell anemia.
    Am J Hematol. 2022 Jul 14. doi: 10.1002/ajh.26664.
    >> Share

  9. MINETTI G, Bogdanova AY, Mairbaurl H, Kaestner L, et al
    Space anemia unexplained: Red blood cells seem to be space-proof.
    Am J Hematol. 2022 Jul 14. doi: 10.1002/ajh.26663.
    >> Share

  10. KRALOVA B, Sochorcova L, Song J, Jahoda O, et al
    Developmental changes in iron metabolism and erythropoiesis in mice with human gain-of-function erythropoietin receptor.
    Am J Hematol. 2022 Jul 11. doi: 10.1002/ajh.26658.
    >> Share

  11. XIAOHUA L, Liu Y, Qu C, Mol B, et al
    The association of iron deficiency anemia, thrombocytosis at delivery and postpartum venous thromboembolism.
    Am J Hematol. 2022 Jul 9. doi: 10.1002/ajh.26657.
    >> Share

  12. BREWIN JN, Nardo-Marino A, Stuart-Smith S, El Hoss S, et al
    The pleiotropic effects of alpha thalassemia on HbSS and HbSC sickle cell disease: reduced erythrocyte cation co-transport activity, serum erythropoietin, and transfusion burden, do not translate into increased survival.
    Am J Hematol. 2022 Jul 8. doi: 10.1002/ajh.26652.
    >> Share

  13. WESTIN ER, Tsao DS, Atay O, Landry BP, et al
    Validation of single-gene noninvasive prenatal testing for sickle cell disease.
    Am J Hematol. 2022;97:E270-E273.
    >> Share

  14. DE LUNA G, Habibi A, Odievre MH, Guillet H, et al
    Blood exchange transfusion with dexamethasone and Tocilizumab for management of hospitalized patients with sickle cell disease and severe COVID-19: Preliminary evaluation of a novel algorithm.
    Am J Hematol. 2022;97:E260-E264.
    >> Share

  15. VITTAL A, Alao H, Hercun J, Sharma B, et al
    Safety of liver biopsy in patients with sickle cell related liver disease: A single-center experience.
    Am J Hematol. 2022;97:E257-E260.
    >> Share

  16. VAN DIJK MJ, Rab MAE, van Oirschot BA, Bos J, et al
    Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open-label study.
    Am J Hematol. 2022;97:E226-E229.
    >> Share

  17. WONG KH, Soffer GK
    Characteristics and prevalence of antibiotic allergies in patients with sickle cell disease: A single-center retrospective study.
    Am J Hematol. 2022;97:E247-E249.
    >> Share

  18. GIANNOTTA JA, Fattizzo B, Bortolotti M, Girmenia C, et al
    SARS-CoV-2 vaccination in patients with paroxysmal nocturnal hemoglobinuria: An Italian multicenter survey.
    Am J Hematol. 2022;97:E229-E232.
    >> Share

    June 2022
  19. KOURY MJ, Agarwal R, Chertow GM, Eckardt KU, et al
    Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease.
    Am J Hematol. 2022 Jun 25. doi: 10.1002/ajh.26644.
    >> Share

  20. BAIN BJ, Myburgh J, Hann A, Layton DM, et al
    Voxelotor in sickle cell disease.
    Am J Hematol. 2022;97:830-832.
    >> Share

  21. YOUNG DJ, Fan X, Groarke EM, Patel B, et al
    Long-term eltrombopag for bone marrow failure depletes iron.
    Am J Hematol. 2022;97:791-801.
    >> Share

    May 2022
  22. KRONER BL, Hankins JS, Pugh N, Kutlar A, et al
    Pregnancy outcomes with hydroxyurea use in women with sickle cell disease.
    Am J Hematol. 2022;97:603-612.
    >> Share

    April 2022
  23. VAN VUREN A, Kerkhoffs JL, Schols S, Rijneveld A, et al
    Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial. NIH.
    Am J Hematol. 2022 Apr 26. doi: 10.1002/ajh.26581.
    >> Share

  24. NAAMI N, Borkhardt A, Yoshimi A, Grinstein L, et al
    13-month-old girl with hyporegenerative macrocytic anemia due to Brown-Vialetto-Van Laere syndrome 2.
    Am J Hematol. 2022 Apr 20. doi: 10.1002/ajh.26573.
    >> Share

  25. PLESSIER A, Esposito-Farese M, Baiges A, Shukla A, et al
    Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications.
    Am J Hematol. 2022;97:431-439.
    >> Share

  26. AYGUN B, Bello A, Thompson AA, Davis L, et al
    Clinical phenotypes of three children with sickle cell disease caused by HbS/Sicilian (deltabeta)(0) -thalassemia deletion.
    Am J Hematol. 2022;97:E156-E158.
    >> Share

  27. SIVAGURU G, Simini G, Bain BJ
    Persistent neonatal jaundice resulting from hereditary pyropoikilocytosis.
    Am J Hematol. 2022;97:506-507.
    >> Share

    March 2022
  28. ARLET JB, Lionnet F, Khimoud D, Joseph L, et al
    Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France.
    Am J Hematol. 2022;97:E86-E91.
    >> Share

  29. SCHWARTZ JD, Barcellini W, Grace RF, Bianchi P, et al
    Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD.
    Am J Hematol. 2022;97:E120-E125.
    >> Share

  30. CURTIS SA, Betancourt J, Kottapalli N, Campbell S, et al
    Voxelotor use in adults with sickle cell disease in a real-world setting.
    Am J Hematol. 2022;97:E125-E128.
    >> Share

  31. BRADFORD C, Miodownik H, Thomas M, Ogu UO, et al
    Patient-focused inquiry on hydroxyurea therapy adherence and reasons for discontinuation in adults with sickle cell disease.
    Am J Hematol. 2022;97:E93-E95.
    >> Share

  32. ALLALI S, Chhun S, de Montalembert M, Heilbronner C, et al
    Tocilizumab for severe acute chest syndrome in a child with sickle cell disease and dramatically high interleukin-6 values in endotracheal and pleural fluids.
    Am J Hematol. 2022;97:E81-E83.
    >> Share

    February 2022
  33. KUTER DJ, Rogers KA, Boxer MA, Choi M, et al
    Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.
    Am J Hematol. 2022 Feb 18. doi: 10.1002/ajh.26508.
    >> Share

  34. OLUPOT-OLUPOT P, Connon R, Kiguli S, Opoka RO, et al
    A predictive algorithm for identifying children with sickle cell anemia among children admitted to hospital with severe anemia in Africa.
    Am J Hematol. 2022 Feb 11. doi: 10.1002/ajh.26492.
    >> Share

  35. FIELDS ME, Mirro AE, Binkley MM, Guilliams KP, et al
    Cerebral Oxygen Metabolic Stress is Increased in Children with Sickle Cell Anemia Compared to Anemic Controls.
    Am J Hematol. 2022 Feb 3. doi: 10.1002/ajh.26485.
    >> Share

  36. ANGELI AM, Megna B, Mazepa M, Ivy ZK, et al
    Transfusion-Dependent Anemia Secondary to Vitamin C Deficiency.
    Am J Hematol. 2022 Feb 2. doi: 10.1002/ajh.26484.
    >> Share

  37. LONGO F, Gianesin B, Voi V, Motta I, et al
    Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.
    Am J Hematol. 2022;97:E75-E78.
    >> Share

  38. PATNAIK MM, Santini V
    Targeting ineffective hematopoiesis in myelodysplastic syndromes.
    Am J Hematol. 2022;97:171-173.
    >> Share

  39. ANDOLFO I, Alper SL, Iolascon A
    Nobel prize in physiology or medicine 2021, receptors for temperature and touch: Implications for hematology.
    Am J Hematol. 2022;97:168-170.
    >> Share

  40. TVEDT THA, Steien E, Ovrebo B, Haaverstad R, et al
    Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery.
    Am J Hematol. 2022;97:E51-E54.
    >> Share

    January 2022
  41. CHIN-YEE B, Cheong I, Matyashin M, Lazo-Langner A, et al
    Serum erythropoietin levels in 696 patients investigated for erythrocytosis with JAK2 mutation analysis.
    Am J Hematol. 2022 Jan 19. doi: 10.1002/ajh.26471.
    >> Share

  42. DORES GM, Nayernama A, Cheng C, Moureaud C, et al
    Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
    Am J Hematol. 2022 Jan 5. doi: 10.1002/ajh.26454.
    >> Share

  43. FEJTKOVA M, Sukova M, Hlozkova K, Skvarova Kramarzova K, et al
    TLR8/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins.
    Am J Hematol. 2022 Jan 3. doi: 10.1002/ajh.26452.
    >> Share

    Primary myelofibrosis in untreated sickle cell disease: Are adult patients at higher risk for developing hematological myeloid neoplasms?
    Am J Hematol. 2022;97:4-6.
    >> Share

  45. REYES LZ, Figueroa J, Leake D, Khemani K, et al
    Safety of intravenous arginine therapy in children with sickle cell disease hospitalized for vaso-occlusive pain: A randomized placebo-controlled trial in progress.
    Am J Hematol. 2022;97:E21-E24.
    >> Share

  46. FORD AL, Hsu HC, Binkley MM, Rogers S, et al
    Probing single-cell oxygen reserve in sickled erythrocytes via in vivo photoacoustic microscopy.
    Am J Hematol. 2022;97:E11-E14.
    >> Share

  47. GREEN SE, Singh ZN, Baer MR
    Primary myelofibrosis in a patient with sickle cell disease.
    Am J Hematol. 2022;97:160-161.
    >> Share

    December 2021
  48. RUIZ MA, Shah BN, Ren G, Shuey D, et al
    Thrombomodulin and Multi-Organ Failure in Sickle Cell Anemia.
    Am J Hematol. 2021 Dec 20. doi: 10.1002/ajh.26443.
    >> Share

  49. MUSALLAM KM, Vitrano A, Meloni A, Addario Pollina S, et al
    Risk of mortality from anemia and iron overload in non-transfusion-dependent beta-thalassemia.
    Am J Hematol. 2021 Dec 4. doi: 10.1002/ajh.26428.
    >> Share

  50. JOHNSON S, Gordeuk VR, Machado R, Gibbs JSR, et al
    Exercise-induced changes of vital signs in adults with sickle cell disease.
    Am J Hematol. 2021;96:1630-1638.
    >> Share

    November 2021
  51. GERBER GF, DeZern AE, Chaturvedi S, Brodsky RA, et al
    A 15-year, single institution experience of anticoagulation management in paroxysmal nocturnal hemoglobinuria patients on terminal complement inhibition with history of thromboembolism.
    Am J Hematol. 2021 Nov 20. doi: 10.1002/ajh.26414.
    >> Share

  52. FATTIZZO B, Giannotta JA, Cecchi N, Barcellini W, et al
    SARS-CoV-2 vaccination in patients with autoimmune cytopenias: The experience of a reference center.
    Am J Hematol. 2021;96:E413-E416.
    >> Share

  53. HENRY DH, Glaspy J, Harrup R, Mittelman M, et al
    Roxadustat for the Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome: Open-label, Dose-selection, Lead-in Stage of a Phase 3 Study.
    Am J Hematol. 2021 Nov 1. doi: 10.1002/ajh.26397.
    >> Share

  54. KOUNTOURIS P, Stephanou C, Archer N, Bonifazi F, et al
    The International Hemoglobinopathy Research Network (INHERENT): An international initiative to study the role of genetic modifiers in hemoglobinopathies.
    Am J Hematol. 2021;96:E416-E420.
    >> Share

  55. MARTIN ES, Ferrer A, Mangaonkar AA, Khan SP, et al
    Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes.
    Am J Hematol. 2021;96:1450-1460.
    >> Share

  56. LONGORIA JN, Pugh NL, Gordeuk V, Hsu LL, et al
    Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease.
    Am J Hematol. 2021;96:1396-1406.
    >> Share

  57. MUSALLAM KM, Bou-Fakhredin R, Cappellini MD, Taher AT, et al
    2021 update on clinical trials in beta-thalassemia.
    Am J Hematol. 2021;96:1518-1531.
    >> Share

  58. HEBBEL RP, Vercellotti GM
    Multiple inducers of endothelial NOS (eNOS) dysfunction in sickle cell disease.
    Am J Hematol. 2021;96:1505-1517.
    >> Share

    October 2021
  59. MAKHARADZE T, Boccia R, Krupa A, Blackman N, et al
    Efficacy and Safety of Ferric Carboxymaltose Infusion in Reducing Anemia in Patients Receiving Chemotherapy for Nonmyeloid Malignancies: a Randomized, Placebo-Controlled Study (IRON CLAD).
    Am J Hematol. 2021 Oct 15. doi: 10.1002/ajh.26376.
    >> Share

  60. COX HD, Miller GD, Manandhar A, Husk JD, et al
    Tracking immature reticulocyte proteins for improved detection of recombinant human erythropoietin (rhEPO) abuse.
    Am J Hematol. 2021 Oct 9. doi: 10.1002/ajh.26368.
    >> Share

  61. ASPERTI M, Brilli E, Denardo A, Gryzik M, et al
    Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments.
    Am J Hematol. 2021;96:1253-1263.
    >> Share

  62. DE MONTALEMBERT M, Voskaridou E, Oevermann L, Cannas G, et al
    Real-Life experience with hydroxyurea in patients with sickle cell disease: Results from the prospective ESCORT-HU cohort study.
    Am J Hematol. 2021;96:1223-1231.
    >> Share

  63. PIATTI G, Giuditta M, Pierini A, Consonni D, et al
    Muscular de-conditioning and reduced cardiac inotropism due to iron deposition reduce exercise tolerance in beta thalassemia major.
    Am J Hematol. 2021;96:E370-E373.
    >> Share

    September 2021
  64. VIRK ZM, Patel AA, Leaf RK, Al-Samkari H, et al
    Predictors of Mortality and Outcomes of Liver Transplant in Spur Cell Hemolytic Anemia.
    Am J Hematol. 2021 Sep 22. doi: 10.1002/ajh.26359.
    >> Share

  65. PETIT AF, Kulasekararaj AG, Eikema DJ, Maschan A, et al
    Upfront unrelated donor Hematopoietic stem cell transplantation in patients with idiopathic aplastic anemia: a retrospective study of the Severe Aplastic Anemia Working Party of European Bone Marrow Transplantation.
    Am J Hematol. 2021 Sep 22. doi: 10.1002/ajh.26354.
    >> Share

  66. MEZNARICH JA, Rets A, Agarwal AM, Christensen RD, et al
    Novel, De Novo, Beta-Globin Variant with Decreased Oxygen Affinity (HBB:C.317T>A, "Hemoglobin St. George") in a Healthy Child with Low Oxygen Saturations and Anemia.
    Am J Hematol. 2021 Sep 22. doi: 10.1002/ajh.26356.
    >> Share

  67. YE L, Jing L, Guo J, Zhao X, et al
    Red Blood Cell Lifespan is Reduced in Severe Aplastic Anemia and Improves with Response to Immunosuppressive Treatment.
    Am J Hematol. 2021 Sep 2. doi: 10.1002/ajh.26344.
    >> Share

  68. D'HUMIERES T, Savale L, Inamo J, Deux JF, et al
    Cardiovascular phenotypes predict clinical outcomes in sickle cell disease: An echocardiography-based cluster analysis.
    Am J Hematol. 2021;96:1166-1175.
    >> Share

  69. ROGER C, Lionnet F, Mattioni S, Livrozet M, et al
    Risk factors for CKD stage II onset in a prospective cohort of homozygous sickle cell adults.
    Am J Hematol. 2021;96:1147-1155.
    >> Share

  70. MANSOUR-HENDILI L, Egee S, Monedero-Alonso D, Bouyer G, et al
    Multiple thrombosis in a patient with Gardos channelopathy and a new KCNN4 mutation.
    Am J Hematol. 2021;96:E318-E321.
    >> Share

  71. VAN VUREN AJ, Minniti CP, Mendelsohn L, Baird JH, et al
    Lactate dehydrogenase to carboxyhemoglobin ratio as a biomarker of heme release to heme processing is associated with higher tricuspid regurgitant jet velocity and early death in sickle cell disease.
    Am J Hematol. 2021;96:E315-E318.
    >> Share

    August 2021
  72. PEREZ BOTERO J, Reese JA, George JN, McIntosh JJ, et al
    Severe Thrombocytopenia and Microangiopathic Hemolytic Anemia in Pregnancy: A Guide for the Consulting Hematologist.
    Am J Hematol. 2021 Aug 23. doi: 10.1002/ajh.26328.
    >> Share

  73. DEXTER D, Layton DM, Kiritkumar K, Bain BJ, et al
    Peripheral blood features of iron overload in post-splenectomy, type I congenital dyserythropoietic anemia.
    Am J Hematol. 2021 Aug 20. doi: 10.1002/ajh.26327.
    >> Share

  74. SHIMANO KA, Narla A, Rose MJ, Gloude NJ, et al
    Diagnostic work-up for severe aplastic anemia in children: Consensus of the North American Pediatric Aplastic Anemia Consortium.
    Am J Hematol. 2021 Aug 3. doi: 10.1002/ajh.26310.
    >> Share

  75. PEREZ-LAMAS L, Moreno-Jimenez G, Tenorio-Nunez MC, Velazquez-Kennedy K, et al
    Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease.
    Am J Hematol. 2021;96:E288-E291.
    >> Share

  76. BOU-FAKHREDIN R, Daadaa H, Koussa S, Abou Nasr T, et al
    SARS-CoV-2 infection in patients with beta-thalassemia: Experience from Lebanon.
    Am J Hematol. 2021;96:E285-E288.
    >> Share

  77. HAYFRON-BENJAMIN CF, Asare EV, Boafor T, Olayemi E, et al
    Low FEV1 is associated with fetal death in pregnant women with sickle cell disease.
    Am J Hematol. 2021;96:E303-E306.
    >> Share

  78. EDJLALI M, Gobin-Metteil MP, Mele N, Maier B, et al
    Transcranial color-coded duplex sonography reliably identifies intracranial vasculopathy in adult patients with sickle cell disease.
    Am J Hematol. 2021;96:961-967.
    >> Share

  79. VU C, Bush A, Choi S, Borzage M, et al
    Reduced global cerebral oxygen metabolic rate in sickle cell disease and chronic anemias.
    Am J Hematol. 2021;96:901-913.
    >> Share

  80. KNEE KM, Jasuja R, Barakat A, Rao D, et al
    PF-07059013: A non-covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell disease.
    Am J Hematol. 2021;96:E272-E275.
    >> Share

  81. MALECKA A, Troen G, Delabie J, Malecki J, et al
    The mutational landscape of cold agglutinin disease: CARD11 and CXCR4 mutations are correlated with lower hemoglobin levels.
    Am J Hematol. 2021;96:E279-E283.
    >> Share

  82. JANKOVSKY N, Caulier A, Demagny J, Guitton C, et al
    Recent advances in the pathophysiology of PIEZO1-related hereditary xerocytosis.
    Am J Hematol. 2021;96:1017-1026.
    >> Share

  83. FAN BE, Cao L, Gallardo CA, Lee SMS, et al
    Myeloid and lymphoid vacuolation in VEXAS syndrome.
    Am J Hematol. 2021;96:1056-1057.
    >> Share

    July 2021
  84. HANSEN DL, Berentsen S, Fattizzo B, Hansen PL, et al
    Seasonal variation in the incidence of cold agglutinin disease in Norway, Denmark, and Italy.
    Am J Hematol. 2021;96:E262-E265.
    >> Share

  85. WAHEED A, Kuter DJ
    Iron overload after complement inhibitor treatment of Paroxysmal Nocturnal Hemoglobinuria.
    Am J Hematol. 2021;96:E235-E237.
    >> Share

  86. MONTALBAN-BRAVO G, Kanagal-Shamanna R, Darbaniyan F, Siddiqui MT, et al
    Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS).
    Am J Hematol. 2021;96:E246-E249.
    >> Share

  87. KULASEKARARAJ AG, Brodsky RA, Hill A
    Monitoring of patients with paroxysmal nocturnal hemoglobinuria on a complement inhibitor.
    Am J Hematol. 2021;96:E232-E235.
    >> Share

    June 2021
  88. GURUNG K, Bain BJ
    A normal mean cell volume does not exclude a diagnosis of megaloblastic anemia.
    Am J Hematol. 2021 Jun 24. doi: 10.1002/ajh.26283.
    >> Share

  89. KIRK SE, Scheurer ME, Bernhardt MB, Mahoney DH, et al
    Phosphorus levels in children treated with intravenous ferric carboxymaltose.
    Am J Hematol. 2021;96:E215-E218.
    >> Share

  90. PANAGIOTA V, Meggendorfer M, Kubasch AS, Gabdoulline R, et al
    Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q.
    Am J Hematol. 2021;96:E207-E210.
    >> Share

  91. ZHANG X, Yang Y, Zhang H, Du Z, et al
    A rare complex rearrangement in the beta-globin gene cluster causing a novel homozygous (G) gamma((A) gammadeltabeta)(0) -thalassemia.
    Am J Hematol. 2021;96:E189-E193.
    >> Share

    May 2021
  92. RAMIREZ MJ, Pujol R, Trujillo-Quintero JP, Minguillon J, et al
    Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients.
    Am J Hematol. 2021 May 13. doi: 10.1002/ajh.26234.
    >> Share

  93. KIM SJ, Song J, Reading NS, Lautersztain J, et al
    Novel mechanism of hereditary pyropoikilocytosis phenotype due to co-inheritance of beta globin and alpha spectrin mutations.
    Am J Hematol. 2021;96:E150-E154.
    >> Share

  94. KALANTAR-ZADEH K, Ganz T, Trumbo H, Seid MH, et al
    Parenteral iron therapy and phosphorus homeostasis: A review.
    Am J Hematol. 2021;96:606-616.
    >> Share

  95. BAIN BJ
    Alpha chain inclusions in peripheral blood erythroblasts and erythrocytes.
    Am J Hematol. 2021;96:630-631.
    >> Share

    April 2021
  96. MAQUET J, Lafaurie M, Walter O, Sailler L, et al
    Epidemiology of autoimmune hemolytic anemia: a nationwide population-based study in France.
    Am J Hematol. 2021 Apr 30. doi: 10.1002/ajh.26213.
    >> Share

  97. BARCELLINI W, Zaninoni A, Giannotta JA, Merati G, et al
    Circulating extracellular vesicles and cytokines in congenital and acquired hemolytic anemias.
    Am J Hematol. 2021;96:E129-E132.
    >> Share

  98. MINNITI CP, Knight-Madden J, Tonda M, Gray S, et al
    The impact of voxelotor treatment on leg ulcers in patients with sickle cell disease.
    Am J Hematol. 2021;96:E126-E128.
    >> Share

  99. AL-ALI AK, Alsulaiman A, Alfarhan M, Safaya S, et al
    Sickle cell disease in the Eastern Province of Saudi Arabia: Clinical and laboratory features.
    Am J Hematol. 2021;96:E117-E121.
    >> Share

  100. MCGRATH M, Quint EH, Weyand AC
    Depression in adolescents and young adults with heavy menstrual bleeding in a referral clinic setting.
    Am J Hematol. 2021;96:E105-E108.
    >> Share

  101. ARCHULETA J, van der Graaf M, Kaptein FHJ, Althaus L, et al
    Sudden death due to massive bone marrow sequestration crisis in a patient with sickle cell disease.
    Am J Hematol. 2021;96:E100-E102.
    >> Share

  102. OSUNKWO I, Andemariam B, Minniti CP, Inusa BPD, et al
    Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY).
    Am J Hematol. 2021;96:404-417.
    >> Share

  103. LANZKRON S, Smith-Whitley K
    Swaying sickle cell research forward in support of patient reported outcomes.
    Am J Hematol. 2021;96:402-403.
    >> Share

    March 2021
  104. PATNAIK MM, Tefferi A
    Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management".
    Am J Hematol. 2021;96:379-394.
    >> Share

  105. DENTON CC, Shah P, Suriany S, Liu H, et al
    Loss of alpha-globin genes in human subjects is associated with improved nitric oxide-mediated vascular perfusion.
    Am J Hematol. 2021;96:277-281.
    >> Share

  106. MUSALLAM KM, Rivella S, Taher AT
    Management of non-transfusion-dependent beta-thalassemia (NTDT): The next 5 years.
    Am J Hematol. 2021;96:E57-E59.
    >> Share

    February 2021
  107. ZUBICARAY J, Pagliara D, Sevilla J, Eikema DJ, et al
    Haplo-identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: results from the Severe Aplastic Anemia Working Party of the EBMT.
    Am J Hematol. 2021 Feb 19. doi: 10.1002/ajh.26135.
    >> Share

  108. ROMANA M, Reminy K, Moeckesch B, Charlot K, et al
    Loss of alpha globin genes is associated with improved microvascular function in patients with sickle cell anemia.
    Am J Hematol. 2021 Feb 13. doi: 10.1002/ajh.26126.
    >> Share

  109. AUERBACH M, Henry D, DeLoughery TG
    Intravenous ferric derisomaltose for the treatment of iron deficiency anemia.
    Am J Hematol. 2021 Feb 13. doi: 10.1002/ajh.26124.
    >> Share

  110. KARKOSKA K, Quinn CT, Niss O, Pfeiffer A, et al
    Hydroyxurea improves cerebral oxygen saturation in children with sickle cell anemia.
    Am J Hematol. 2021 Feb 3. doi: 10.1002/ajh.26120.
    >> Share

  111. LEBENSBURGER JD, Aban I, Hilliard LM, Feig DI, et al
    Hyperuricemia and Abnormal Nocturnal Dipping Impact Glomerular Filtration Rate in Patients with Sickle Cell Anemia.
    Am J Hematol. 2021 Feb 1. doi: 10.1002/ajh.26115.
    >> Share

  112. MUSALLAM KM, Cappellini MD, Viprakasit V, Kattamis A, et al
    Revisiting the non-transfusion-dependent (NTDT) vs. transfusion-dependent (TDT) thalassemia classification 10 years later.
    Am J Hematol. 2021;96:E54-E56.
    >> Share

  113. SCHMIDT PJ, Fitzgerald K, Butler JS, Fleming MD, et al
    Global loss of Tfr2 with concomitant induced iron deficiency greatly ameliorates the phenotype of a murine thalassemia intermedia model.
    Am J Hematol. 2021;96:251-257.
    >> Share

    January 2021
  114. LUNATI A, Petit A, Lapillonne H, Gameiro C, et al
    VPS4A mutation in syndromic congenital hemolytic anemia without obvious signs of dyserythropoiesis.
    Am J Hematol. 2021 Jan 18. doi: 10.1002/ajh.26099.
    >> Share

  115. GLADWIN MT, Kato GJ, Gordeuk VR
    Identifying adolescent and young adult patients with sickle cell disease at highest risk of death.
    Am J Hematol. 2021;96:9-11.
    >> Share

  116. RAB MAE, Kanne CK, Bos J, van Oirschot BA, et al
    Oxygen gradient ektacytometry-derived biomarkers are associated with vaso-occlusive crises and correlate with treatment response in sickle cell disease.
    Am J Hematol. 2021;96:E29-E32.
    >> Share

  117. ROSANWO TO, Kean LS, Archer NM
    End the pain: Start with antiracism.
    Am J Hematol. 2021;96:4-6.
    >> Share

  118. OGU UO, Thomas M, Chan F, Vattappally L, et al
    L-glutamine use in adults with sickle cell disease: Clinical trials where success meets reality.
    Am J Hematol. 2021;96:E38-E40.
    >> Share

  119. CHALACHEVA P, Ji Y, Rosen CL, DeBaun MR, et al
    Nocturnal peripheral vasoconstriction predicts the frequency of severe acute pain episodes in children with sickle cell disease.
    Am J Hematol. 2021;96:60-68.
    >> Share

  120. COSTA E, Tibalinda P, Sterzi E, Leufkens HMG, et al
    Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost.
    Am J Hematol. 2021;96:E2-E5.
    >> Share

  121. SHAH P, Suriany S, Kato R, Bush AM, et al
    Tricuspid regurgitant jet velocity and myocardial tissue Doppler parameters predict mortality in a cohort of patients with sickle cell disease spanning from pediatric to adult age groups - revisiting this controversial concept after 16 years of additi
    Am J Hematol. 2021;96:31-39.
    >> Share

    December 2020
  122. KARKOSKA K, Quinn CT, Clapp K, McGann PT, et al
    Severe infusion-related reaction to crizanlizumab in an adolescent with sickle cell disease.
    Am J Hematol. 2020;95:E338-E339.
    >> Share

  123. COHEN J, Khudanyan A, Lu J, Wing J, et al
    A multicenter study evaluating the effectiveness and safety of single-dose low molecular weight iron dextran vs single-dose ferumoxytol for the treatment of iron deficiency.
    Am J Hematol. 2020;95:1572-1577.
    >> Share

    November 2020
  124. DAVIS BH
    Assay for "fetal hemoglobin levels" in erythrocytes: Impact of new In Vitro Diagnostics regulation and expanded applications in sickle cell disease management.
    Am J Hematol. 2020;95:1230-1232.
    >> Share

    Can any new thalassemia therapy achieve a better than 97.4% cure rate?
    Am J Hematol. 2020;95:1233-1234.
    >> Share

  126. HE Y, Jiang H, Li C, Zhu Y, et al
    Long-term results of the NF-08-TM protocol in stem cell transplant for patients with thalassemia major: A multi-center large-sample study.
    Am J Hematol. 2020;95:E297-E299.
    >> Share

  127. RUSSO R, Marra R, Andolfo I, Manna F, et al
    Uridine treatment normalizes the congenital dyserythropoietic anemia type II-like hematological phenotype in a patient with homozygous mutation in the CAD gene.
    Am J Hematol. 2020;95:1423-1426.
    >> Share

  128. MERLET AN, Feasson L, Bartolucci P, Hourde C, et al
    Muscle structural, energetic and functional benefits of endurance exercise training in sickle cell disease.
    Am J Hematol. 2020;95:1257-1268.
    >> Share

  129. HEBERT N, Rakotoson MG, Bodivit G, Audureau E, et al
    Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
    Am J Hematol. 2020;95:1235-1245.
    >> Share

  130. KUCUKAL E, Man Y, Hill A, Liu S, et al
    Whole blood viscosity and red blood cell adhesion: Potential biomarkers for targeted and curative therapies in sickle cell disease.
    Am J Hematol. 2020;95:1246-1256.
    >> Share

  131. DE CASTRO C, Grossi F, Weitz IC, Maciejewski J, et al
    C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab.
    Am J Hematol. 2020;95:1334-1343.
    >> Share

    October 2020
  132. POLLYEA DA, Pratz K, Letai A, Jonas BA, et al
    Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: long term follow-up from a Phase 1b study.
    Am J Hematol. 2020 Oct 29. doi: 10.1002/ajh.26039.
    >> Share

  133. ONALO R, Cooper P, Cilliers A, Vorster BC, et al
    Randomized Control Trial of Oral Arginine Therapy for Children with Sickle Cell Anemia Hospitalized for Pain in Nigeria.
    Am J Hematol. 2020 Oct 19. doi: 10.1002/ajh.26028.
    >> Share

  134. WOLF M, Auerbach M, Kalra PA, Glaspy J, et al
    Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON-IDA/NEPHRO trials.
    Am J Hematol. 2020 Oct 7. doi: 10.1002/ajh.26015.
    >> Share

    September 2020
  135. DEBEER T, Jordan LC, Lee CA, Patel NJ, et al
    Evidence of transfusion-induced reductions in cerebral capillary shunting in sickle cell disease.
    Am J Hematol. 2020;95:E228-E230.
    >> Share

  136. SONI S
    Gene therapies for transfusion dependent beta-thalassemia: Current status and critical criteria for success.
    Am J Hematol. 2020;95:1099-1112.
    >> Share

  137. GALADANCI NA, Abdullahi SU, Ali Abubakar S, Wudil Jibir B, et al
    Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.
    Am J Hematol. 2020;95:E247-E250.
    >> Share

  138. GEORGE A, Dinu B, Estrada N, Minard CG, et al
    Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease.
    Am J Hematol. 2020;95:E242-E244.
    >> Share

  139. KNISELY MR, Pugh N, Kroner B, Masese R, et al
    Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium.
    Am J Hematol. 2020;95:1066-1074.
    >> Share

  140. TISDALE JF, Pierciey FJ Jr, Bonner M, Thompson AA, et al
    Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial.
    Am J Hematol. 2020;95:E239-E242.
    >> Share

  141. SCARAMELLINI N, Consonni D, Cassinerio E, Arighi C, et al
    A holistic approach to iron chelation therapy in transfusion-dependent thalassemia patients with serum ferritin below 500 mug/L.
    Am J Hematol. 2020;95:E230-E232.
    >> Share

  142. SIDANA S, Murray DL, Dasari S, Go RS, et al
    Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease.
    Am J Hematol. 2020;95:E222-E225.
    >> Share

  143. TSEU B, Siow W, Pushkaran B, Cheesebrough B, et al
    Beta thalassemia major and Noonan syndrome - Two genetic disorders manifest in the blood film.
    Am J Hematol. 2020;95:1113-1114.
    >> Share

    August 2020
  144. WILDING C, Pelling D, Lund K, Bain BJ, et al
    Erythrophagocytosis by monocytes - an unusual observation in autoimmune hemolytic anemia.
    Am J Hematol. 2020 Aug 18. doi: 10.1002/ajh.25966.
    >> Share

  145. JORDAN LC, Rodeghier M, Donahue MJ, DeBaun MR, et al
    Reduction in TCD velocity after regular blood transfusion therapy is associated with a change in hemoglobin S fraction in sickle cell anemia.
    Am J Hematol. 2020 Aug 10. doi: 10.1002/ajh.25954.
    >> Share

  146. NAYMAGON L, Berwick S, Kessler A, Lancman G, et al
    The emergence of methemoglobinemia amidst the COVID-19 pandemic.
    Am J Hematol. 2020;95:E196-E197.
    >> Share

  147. TAHER AT, Bou-Fakhredin R, Kreidieh F, Motta I, et al
    Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations.
    Am J Hematol. 2020;95:E208-E210.
    >> Share

  148. KUIPERS MT, van Zwieten R, Heijmans J, Rutten CE, et al
    Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine.
    Am J Hematol. 2020;95:E194-E196.
    >> Share

  149. ODIEVRE MH, de Marcellus C, Ducou Le Pointe H, Allali S, et al
    Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome.
    Am J Hematol. 2020;95:E192-E194.
    >> Share

  150. MOTTA I, Migone De Amicis M, Pinto VM, Balocco M, et al
    SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience.
    Am J Hematol. 2020;95:E198-E199.
    >> Share

  151. MITRA A, Dwyre DM, Schivo M, Thompson GR 3rd, et al
    Leukoerythroblastic reaction in a patient with COVID-19 infection.
    Am J Hematol. 2020;95:999-1000.
    >> Share

  152. MACRAE FL, Peacock-Young B, Bowman P, Baker SR, et al
    Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab.
    Am J Hematol. 2020;95:944-952.
    >> Share

  153. HARPER K, McIlwaine L, Leach M, Bain BJ, et al
    Giant proerythroblasts in pure red cell aplasia due to parvovirus B19 infection in a patient with rheumatoid arthritis.
    Am J Hematol. 2020;95:990-991.
    >> Share

    July 2020
  154. DOMINGUES-HAMDI E, Vasseur C, Pakdaman S, Moutereau S, et al
    Hydroxycarbamide decreases the free alpha-hemoglobin pool in red blood cells of adult patients with sickle cell anemia.
    Am J Hematol. 2020 Jul 28. doi: 10.1002/ajh.25947.
    >> Share

  155. GORDEUK VR, Shah BN, Zhang X, Thuma PE, et al
    CYB5R3(c) (.350C>G) and G6PD A Alleles Modify Severity of Anemia in Malaria and Sickle Cell Disease.
    Am J Hematol. 2020 Jul 22. doi: 10.1002/ajh.25941.
    >> Share

  156. SONG AB, Kuter DJ, Al-Samkari H
    Characterization of the Rate, Predictors, and Thrombotic Complications of Thrombocytosis in Iron Deficiency Anemia.
    Am J Hematol. 2020 Jul 3. doi: 10.1002/ajh.25925.
    >> Share

  157. DE LUNA G, Habibi A, Deux JF, Colard M, et al
    Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.
    Am J Hematol. 2020;95:876-878.
    >> Share

  158. FAN BE, Ong KH, Chan SSW, Young BE, et al
    Blood and blood product use during COVID-19 infection.
    Am J Hematol. 2020;95:E158-E160.
    >> Share

  159. BEERKENS F, John M, Puliafito B, Corbett V, et al
    COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient.
    Am J Hematol. 2020;95:E154-E156.
    >> Share

  160. NOURAIE M, Darbari DS, Rana S, Minniti CP, et al
    Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study.
    Am J Hematol. 2020;95:766-774.
    >> Share

  161. VAN TUIJN CFJ, Gaartman AE, Nur E, Rijneveld AW, et al
    Incentive spirometry to prevent acute chest syndrome in adults with sickle cell disease; a randomized controlled trial.
    Am J Hematol. 2020;95:E160-E163.
    >> Share

    June 2020
  162. ACHEBE MM, Glaspy J, Kalra PA, Auerbach M, et al
    A six month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON-EXT trial.
    Am J Hematol. 2020 Jun 29. doi: 10.1002/ajh.25920.
    >> Share

  163. NUR E, Gaartman AE, van Tuijn CFJ, Tang MW, et al
    Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19).
    Am J Hematol. 2020;95:725-726.
    >> Share

  164. LIM SH, Dutta D
    Clinicopathologic consequences following discontinuation of rifaximin in patients with sickle cell disease.
    Am J Hematol. 2020;95:E151-E153.
    >> Share

  165. HAUGHTON A, Stylian S, Bain BJ
    Stress erythropoiesis in hereditary spherocytosis.
    Am J Hematol. 2020;95:710-711.
    >> Share

    May 2020
  166. LOFARO T, Bain BJ
    Schistocytosis is not always microangiopathic hemolytic anemia.
    Am J Hematol. 2020 May 10. doi: 10.1002/ajh.25861.
    >> Share

  167. BIANCHI P, Fermo E, Lezon-Geyda K, van Beers EJ, et al
    Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency.
    Am J Hematol. 2020;95:472-482.
    >> Share

  168. SCHMIDT PJ, Hollowell ML, Fitzgerald K, Butler JS, et al
    Mild iron deficiency does not ameliorate the phenotype of a murine erythropoietic protoporphyria model.
    Am J Hematol. 2020;95:492-496.
    >> Share

  169. ROUMENINA LT, Chadebech P, Bodivit G, Vieira-Martins P, et al
    Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy.
    Am J Hematol. 2020;95:456-464.
    >> Share

    Now I Am The Voice: "a journey of self-discovery through the eyes of a Thalassemic".
    Am J Hematol. 2020;95:E105-E107.
    >> Share

    April 2020
  171. PROCHASKA MT, Zhang H, Alavi C, Meltzer DO, et al
    Fatigability: A new perspective on and patient-centered outcome measure for patients with anemia.
    Am J Hematol. 2020 Apr 15. doi: 10.1002/ajh.25803.
    >> Share

  172. GIARDINO S, Peffault de Latour R, Aljurf M, Eikema DJ, et al
    Outcome of Patients with Fanconi Anemia developing myelodysplasia and acute leukemia who received Allogeneic Hematopoietic Stem Cell Transplantation: A retrospective analysis on Behalf of EBMT group.
    Am J Hematol. 2020 Apr 8. doi: 10.1002/ajh.25810.
    >> Share

  173. HWANG SR, O'Dowd T, Markovic SN, Wolanskyj-Spinner AP, et al
    Recurrent Checkpoint Inhibitor-Induced Warm Agglutinin Autoimmune Hemolytic Anemia in a Patient with Metastatic Melanoma.
    Am J Hematol. 2020 Apr 3. doi: 10.1002/ajh.25812.
    >> Share

  174. AL-BUBSEREE B, Leach M, Jones R, Bain BJ, et al
    The hematological effects of copper deficiency.
    Am J Hematol. 2020;95:446.
    >> Share

  175. ESPINOZA J, Shah P, Veluswamy S, Zeltzer L, et al
    Aura and mental stress are associated with reports of pain in sickle cell disease-a pilot study using a mobile application.
    Am J Hematol. 2020;95:E101-E103.
    >> Share

  176. DUTTA D, Li K, Methe B, Lim SH, et al
    Rifaximin on intestinally-related pathologic changes in sickle cell disease.
    Am J Hematol. 2020;95:E83-E86.
    >> Share

  177. VACLAVU L, Petr J, Petersen ET, Mutsaerts HJMM, et al
    Cerebral oxygen metabolism in adults with sickle cell disease.
    Am J Hematol. 2020;95:401-412.
    >> Share

  178. GONDELAUD F, Connes P, Nader E, Renoux C, et al
    Sialic acids rather than glycosaminoglycans affect normal and sickle red blood cell rheology by binding to four major sites on fibrinogen.
    Am J Hematol. 2020;95:E77-E80.
    >> Share

    March 2020
  179. MANARA R, Canna A, Caiazza M, Ponticorvo S, et al
    White matter volume changes in adult beta-thalassemia: negligible and unrelated to anemia and cognitive performances.
    Am J Hematol. 2020 Mar 20. doi: 10.1002/ajh.25790.
    >> Share

  180. CHOI S, Leahy RM, Wood JC
    Lower White Matter Volume in Beta-Thalassemia Associated with Anemia and Cognitive Performance.
    Am J Hematol. 2020 Mar 17. doi: 10.1002/ajh.25787.
    >> Share

  181. IKWUANUSI I, Jordan LC, Lee CA, Patel NJ, et al
    Cerebral hemodynamics and metabolism are similar in sickle cell disease patients with hemoglobin SS and Sbeta(0) thalassemia phenotypes.
    Am J Hematol. 2020;95:E66-E68.
    >> Share

  182. FOY BH, Li A, McClung JP, Ranganath R, et al
    Data-driven physiologic thresholds for iron deficiency associated with hematologic decline.
    Am J Hematol. 2020;95:302-309.
    >> Share

  183. ZHANG X, Shah BN, Zhang W, Saraf SL, et al
    S100B has pleiotropic effects on vaso-occlusive manifestations in sickle cell disease.
    Am J Hematol. 2020;95:E62-E65.
    >> Share

    February 2020
  184. SARNA K, Brittenham GM, Beall CM
    Current WHO hemoglobin thresholds for altitude and misdiagnosis of anemia among Tibetan highlanders.
    Am J Hematol. 2020 Feb 25. doi: 10.1002/ajh.25765.
    >> Share

  185. BELISARIO AR, de Almeida JA, Mendes FG, da Silva DMM, et al
    Prevalence and risk factors for albuminuria and glomerular hyperfiltration in a large cohort of children with sickle cell anemia.
    Am J Hematol. 2020 Feb 21. doi: 10.1002/ajh.25763.
    >> Share

  186. TOLU S, Reyes-Gil M, Ogu UO, Thomas M, et al
    Inherited High Fetal Hemoglobin in Sickle Cell Anemia: Outcomes with Aging High HbF and Sickle Cell.
    Am J Hematol. 2020 Feb 18. doi: 10.1002/ajh.25759.
    >> Share

  187. SCHECKEL CJ, Yanardag Acik D, Ravindran A, Marshall A, et al
    Hapticophagia: Tactile chew cravings in iron deficiency anemia.
    Am J Hematol. 2020 Feb 5. doi: 10.1002/ajh.25749.
    >> Share

  188. EATON WA
    Hemoglobin S polymerization and sickle cell disease: A retrospective on the occasion of the 70th anniversary of Pauling's Science paper.
    Am J Hematol. 2020;95:205-211.
    >> Share

  189. ANDOLFO I, Rosato BE, Manna F, De Rosa G, et al
    Gain-of-function mutations in PIEZO1 directly impair hepatic iron metabolism via the inhibition of the BMP/SMADs pathway.
    Am J Hematol. 2020;95:188-197.
    >> Share

  190. GENDREAU S, Scholer M, Cecchini J, Habibi A, et al
    Cerebral fat embolism in sickle cell disease.
    Am J Hematol. 2020;95:E41-E45.
    >> Share

    January 2020
  191. WALSH K, Blalock DV, Mehler PS
    Hematologic Findings in a Large Sample of Patients with Anorexia Nervosa and Bulimia Nervosa.
    Am J Hematol. 2020 Jan 15. doi: 10.1002/ajh.25732.
    >> Share

    Treating Sickle Cell Anemia: A New Era Dawns.
    Am J Hematol. 2020 Jan 10. doi: 10.1002/ajh.25724.
    >> Share

  193. WILLEN SM, McNeil JB, Rodeghier M, Kerchberger VE, et al
    Haptoglobin genotype predicts severe acute vaso-occlusive pain episodes in children with sickle cell anemia.
    Am J Hematol. 2020 Jan 9. doi: 10.1002/ajh.25728.
    >> Share

  194. QASRAWI A, Arora R, Ramlal R, Munker R, et al
    Allogenic hematopoietic stem cell transplantation for prolonged bone marrow aplasia after chimeric antigen receptor (CAR) T-cell therapy for relapsed diffuse large B-cell lymphoma.
    Am J Hematol. 2020 Jan 9. doi: 10.1002/ajh.25725.
    >> Share

  195. RICHARD F, van Lier JJ, Roubert B, Haboubi T, et al
    Oral ferroportin inhibitor VIT-2763: First-in-human, phase 1 study in healthy volunteers.
    Am J Hematol. 2020;95:68-77.
    >> Share

  196. RAB MAE, Kanne CK, Bos J, Boisson C, et al
    Methodological aspects of the oxygenscan in sickle cell disease: A need for standardization.
    Am J Hematol. 2020;95:E5-E8.
    >> Share

  197. SCHYRR F, Dolci M, Nydegger M, Canellini G, et al
    Perioperative care of children with sickle cell disease: A systematic review and clinical recommendations.
    Am J Hematol. 2020;95:78-96.
    >> Share

  198. BAIN BJ
    Delta beta thalassemia.
    Am J Hematol. 2020;95:116.
    >> Share

    December 2019
  199. TRUDEL G, Shafer J, Laneuville O, Ramsay T, et al
    Characterizing the effect of exposure to microgravity on anemia, more space is worse.
    Am J Hematol. 2019 Dec 9. doi: 10.1002/ajh.25699.
    >> Share

  200. KAKO S, Kanda Y, Onizuka M, Aotsuka N, et al
    Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: a KSGCT prospective study.
    Am J Hematol. 2019 Dec 5. doi: 10.1002/ajh.25693.
    >> Share

  201. NEUBERG D
    Dissecting the web of ischemic stroke, sickle cell trait, and chronic kidney disease.
    Am J Hematol. 2019;94:1302.
    >> Share

    November 2019
  202. ATAGA KI, Wichlan D, Elsherif L, Derebail VK, et al
    A pilot study of the effect of atorvastatin on endothelial function and albuminuria in sickle cell disease.
    Am J Hematol. 2019;94:E299-E301.
    >> Share

  203. ANDOLFO I, Rosato BE, Marra R, De Rosa G, et al
    The BMP-SMAD pathway mediates the impaired hepatic iron metabolism associated with the ERFE-A260S variant.
    Am J Hematol. 2019;94:1227-1235.
    >> Share

  204. HALKES C, de Wreede LC, Knol C, Simand C, et al
    Allogeneic stem cell transplantation for acquired pure red cell aplasia.
    Am J Hematol. 2019;94:E294-E296.
    >> Share

    September 2019
  205. KARKI NR, Auerbach M
    Single total dose infusion of ferumoxytol (1020 mg in 30 minutes) is an improved method of administration of intravenous iron.
    Am J Hematol. 2019;94:E229-E231.
    >> Share

    August 2019
  206. BATHINI S, Holtzman NG, Koka R, Singh Z, et al
    Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab.
    Am J Hematol. 2019;94:E216-E219.
    >> Share

  207. TAHER AT, Cappellini MD, Musallam KM
    Development of a thalassemia-related thrombosis risk scoring system.
    Am J Hematol. 2019;94:E207-E209.
    >> Share

    June 2019
  208. DETTERICH JA, Kato R, Bush A, Chalacheva P, et al
    Sickle cell microvascular paradox-oxygen supply-demand mismatch.
    Am J Hematol. 2019;94:678-688.
    >> Share

  209. DUTTA D, Methe BA, Morris A, Lim SH, et al
    Effects of rifaximin on circulating aged neutrophils in sickle cell disease.
    Am J Hematol. 2019;94:E175-E176.
    >> Share

  210. NANKANJA R, Kadhumbula S, Tagoola A, Geisberg M, et al
    HemoTypeSC Demonstrates >99% Field Accuracy in a Sickle Cell Disease Screening Initiative in Children of Southeastern Uganda.
    Am J Hematol. 2019;94:E164-E166.
    >> Share

  211. DUTTA D, Methe B, Morris A, Lim SH, et al
    Elevated urinary 3-indoxyl sulfate in sickle cell disease.
    Am J Hematol. 2019;94:E162-E164.
    >> Share

  212. ITZEP NP, Jadhav SP, Kanne CK, Sheehan VA, et al
    Spontaneous healing of avascular necrosis of the femoral head in sickle cell disease.
    Am J Hematol. 2019;94:E160-E162.
    >> Share

    May 2019
  213. BRUNSON A, Keegan T, Mahajan A, White R, et al
    High Incidence of Venous Thromboembolism Recurrence in Patients with Sickle Cell Disease.
    Am J Hematol. 2019 May 9. doi: 10.1002/ajh.25508.
    >> Share

  214. RAB MAE, van Oirschot BA, Bos J, Merkx TH, et al
    Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
    Am J Hematol. 2019;94:575-584.
    >> Share

  215. VINER M, Zhou J, Allison D, Han J, et al
    The morbidity and mortality of end stage renal disease in sickle cell disease.
    Am J Hematol. 2019;94:E138-E141.
    >> Share

  216. WALKER AL, Gaydos LM, Farzan R, De Castro L, et al
    Social media discussions provide new insight about perceptions of hydroxyurea in the sickle cell community.
    Am J Hematol. 2019;94:E134-E136.
    >> Share

  217. WEISS M, Parisi Jun M, Sheth S
    Clinical and economic burden of regularly transfused adult patients with beta-thalassemia in the United States: A retrospective cohort study using payer claims.
    Am J Hematol. 2019;94:E129-E132.
    >> Share

    Erythrocyte ATP, a possible therapeutic approach for sickle cell disease.
    Am J Hematol. 2019;94:E117.
    >> Share

  219. BAO EL, Lareau CA, Brugnara C, Fulcher IR, et al
    Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.
    Am J Hematol. 2019;94:522-527.
    >> Share

    April 2019
  220. CHAI Y, Bush AM, Coloigner J, Nederveen AJ, et al
    White matter has impaired resting oxygen delivery in sickle cell patients.
    Am J Hematol. 2019;94:467-474.
    >> Share

  221. KIM TO, Grimes AB, Kirk S, Arulselvan A, et al
    Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi-institutional review.
    Am J Hematol. 2019;94:461-466.
    >> Share

  222. TAHER AT, Origa R, Perrotta S, Kouraklis A, et al
    Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.
    Am J Hematol. 2019;94:E96-E99.
    >> Share

  223. OYEDEJI C, Strouse JJ, Crawford RD, Garrett ME, et al
    A multi-institutional comparison of younger and older adults with sickle cell disease.
    Am J Hematol. 2019;94:E115-E117.
    >> Share

  224. LEBENSBURGER JD, Aban I, Pernell B, Kasztan M, et al
    Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.
    Am J Hematol. 2019;94:417-423.
    >> Share

  225. ALLY M, Magesa P, Luzzatto L
    High frequency of acquired aplastic anemia in Tanzania.
    Am J Hematol. 2019;94:E86-E88.
    >> Share

  226. REES C, Lund K, Bain BJ
    Infantile pyknocytosis.
    Am J Hematol. 2019;94:489-490.
    >> Share

    March 2019
  227. JORDAN LC, Juttukonda MR, Kassim AA, DeBaun MR, et al
    Haploidentical bone marrow transplantation improves cerebral hemodynamics in adults with sickle cell disease.
    Am J Hematol. 2019 Mar 5. doi: 10.1002/ajh.25455.
    >> Share

  228. VERCELLOTTI GM, Dalmasso AP, Schaid TR Jr, Nguyen J, et al
    Critical role of C5a in sickle cell disease.
    Am J Hematol. 2019;94:327-337.
    >> Share

  229. CASALE M, Filosa A, Ragozzino A, Amendola G, et al
    Long-term improvement in cardiac magnetic resonance in beta-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function.
    Am J Hematol. 2019;94:312-318.
    >> Share

  230. RODGERS GM, Kurtti AL, Gilreath JA
    Are eltrombopag plasma and skin hyperpigmentation related? The eyes have it.
    Am J Hematol. 2019;94:394-395.
    >> Share

    February 2019
  231. MARSHALL AL, Mann S, Wolanskyj-Spinner A
    Digital storytelling for hematology education: Interactive thalassemia module for graduate millennial learners.
    Am J Hematol. 2019;94:E66-E67.
    >> Share

  232. DESAI PC, Kendel N, Huang Y, Heinlein M, et al
    Hypoxia in sickle cell disease due to right to left shunting.
    Am J Hematol. 2019;94:E53-E55.
    >> Share

  233. OPPONG SA, Asare EV, Olayemi E, Boafor T, et al
    Multidisciplinary care results in similar maternal and perinatal mortality rates for women with and without SCD in a low-resource setting.
    Am J Hematol. 2019;94:223-230.
    >> Share

  234. GURUPRASAD P, Mannino RG, Caruso C, Zhang H, et al
    Integrated automated particle tracking microfluidic enables high-throughput cell deformability cytometry for red cell disorders.
    Am J Hematol. 2019;94:189-199.
    >> Share

  235. EISENGA MF, Wouters HJCM, Kieneker LM, van der Klauw MM, et al
    Active smoking and macrocytosis in the general population: Two population-based cohort studies.
    Am J Hematol. 2019;94:E45-E48.
    >> Share

  236. TAHER A, Viprakasit V, Cappellini MD, Sutcharitchan P, et al
    Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO((c)) ).
    Am J Hematol. 2019;94:171-176.
    >> Share

  237. SHARARA AI, Rustom LBO, Marrache M, Rimmani HH, et al
    Sofosbuvir/velpatasvir for chronic hepatitis C infection in patients with transfusion-dependent thalassemia.
    Am J Hematol. 2019;94:E43-E45.
    >> Share

  238. TAHER A, Cappellini MD, Viprakasit V, Sutcharitchan P, et al
    Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO((c)) ).
    Am J Hematol. 2019;94:177-183.
    >> Share

    January 2019
  239. KRISHNAMURTI L, Neuberg DS, Sullivan KM, Kamani NR, et al
    Bone Marrow Transplantation for Adolescents and Young Adults with Sickle Cell Disease: Results of a Prospective Multicenter Pilot Study.
    Am J Hematol. 2019 Jan 13. doi: 10.1002/ajh.25401.
    >> Share

  240. BIANCHI P, Fermo E, Glader B, Kanno H, et al
    Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.
    Am J Hematol. 2019;94:149-161.
    >> Share

  241. HAN J, Saraf SL, Molokie RE, Gordeuk VR, et al
    Use of metformin in patients with sickle cell disease.
    Am J Hematol. 2019;94:E13-E15.
    >> Share

  242. HAN J, Saraf SL, Gowhari M, Jain S, et al
    High inpatient dose of opioid at discharge compared to home dose predicts readmission risk in sickle cell disease.
    Am J Hematol. 2019;94:E5-E7.
    >> Share

  243. CHAPMAN MS, Kiritkumar K, Lund K, Bain BJ, et al
    An unusual hemoglobinopathy: compound heterozygosity for hemoglobins C and E.
    Am J Hematol. 2019;94:144.
    >> Share

  244. KUTLAR A, Kanter J, Liles DK, Alvarez OA, et al
    Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis.
    Am J Hematol. 2019;94:55-61.
    >> Share

  245. STEELE C, Sinski A, Asibey J, Hardy-Dessources MD, et al
    Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Am J Hematol. 2019;94:39-45.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016